NZ513828A - Method of increasing bone volume using non-naturally-occurring EP1 selective agonists - Google Patents

Method of increasing bone volume using non-naturally-occurring EP1 selective agonists

Info

Publication number
NZ513828A
NZ513828A NZ513828A NZ51382800A NZ513828A NZ 513828 A NZ513828 A NZ 513828A NZ 513828 A NZ513828 A NZ 513828A NZ 51382800 A NZ51382800 A NZ 51382800A NZ 513828 A NZ513828 A NZ 513828A
Authority
NZ
New Zealand
Prior art keywords
naturally
occurring
bone volume
increasing bone
selective agonists
Prior art date
Application number
NZ513828A
Other languages
English (en)
Inventor
James Richard Hartke
Mark Walden Lundy
Mitchell Anthony Delong
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NZ513828A publication Critical patent/NZ513828A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/559—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing hetero atoms other than oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NZ513828A 1999-03-05 2000-03-01 Method of increasing bone volume using non-naturally-occurring EP1 selective agonists NZ513828A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12306399P 1999-03-05 1999-03-05

Publications (1)

Publication Number Publication Date
NZ513828A true NZ513828A (en) 2001-09-28

Family

ID=22406507

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ513828A NZ513828A (en) 1999-03-05 2000-03-01 Method of increasing bone volume using non-naturally-occurring EP1 selective agonists

Country Status (10)

Country Link
EP (1) EP1158969A2 (ja)
JP (1) JP2002538105A (ja)
AU (1) AU3711900A (ja)
CA (1) CA2366755A1 (ja)
CO (1) CO5150205A1 (ja)
IL (1) IL145128A0 (ja)
NO (1) NO20014192L (ja)
NZ (1) NZ513828A (ja)
PE (1) PE20001552A1 (ja)
WO (1) WO2000051585A2 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006118173A1 (ja) 2005-04-28 2006-11-09 Ono Pharmaceutical Co., Ltd. 経皮吸収製剤
EP2085088A4 (en) 2006-10-26 2012-08-29 Ono Pharmaceutical Co ADHESIVE PREPARATION
US20110038884A1 (en) 2008-04-28 2011-02-17 National University Co., Hamamatsu Univer. School Of Medicine Immunopotentiating agent comprising ep1 agonist
WO2011109729A2 (en) * 2010-03-05 2011-09-09 University Of Rochester Ep1 inhibition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3982016A (en) * 1975-08-06 1976-09-21 Pfizer Inc. Bone deposition by 16-aryl-13,14-dihydro-PGE2 p-biphenyl esters
US4621100A (en) * 1981-09-25 1986-11-04 The Upjohn Company Treatment of osteoporosis with prostaglandins
US4812304A (en) * 1984-12-21 1989-03-14 The Procter & Gamble Company Treatment of osteoporosis
AU2146592A (en) * 1991-05-29 1993-01-08 Sepracor, Inc. Combination of nsaids and prostaglandins and uses therefor
WO1999012551A1 (en) * 1997-09-09 1999-03-18 The Procter & Gamble Company Method of increasing bone volume using non-naturally-occurring fp selective agonists
JP2002527400A (ja) * 1998-10-15 2002-08-27 メルク エンド カムパニー インコーポレーテッド 骨形成刺激方法
WO2000051616A1 (en) * 1999-03-05 2000-09-08 The Procter & Gamble Company Method of increasing bone volume using non-naturally-occurring selective fp agonist and dito ep1 agonist prostaglandin derivatives

Also Published As

Publication number Publication date
NO20014192D0 (no) 2001-08-29
EP1158969A2 (en) 2001-12-05
JP2002538105A (ja) 2002-11-12
CA2366755A1 (en) 2000-09-08
NO20014192L (no) 2001-11-05
IL145128A0 (en) 2002-06-30
WO2000051585A3 (en) 2001-01-25
CO5150205A1 (es) 2002-04-29
AU3711900A (en) 2000-09-21
WO2000051585A2 (en) 2000-09-08
PE20001552A1 (es) 2001-01-30

Similar Documents

Publication Publication Date Title
PL348323A1 (en) Collagen tube for regeneration of nerves and method of obtaining such collagen tube
IL162008A0 (en) System and methods for asychronous synchronization
PL340109A1 (en) Method of obtaining analogues of nucleosides
HK1027986A1 (en) Method of sterilization
ZA988228B (en) Method of increasing bone volume using non-naturally-occurring FP selective agonists
GB2349493B (en) Method of representing an object using shape
GB2356914B (en) Vibrator holder and vibrator attaching method
IL145128A0 (en) Method of increasing bone volume using non-naturally-occurring ep1 selective agonists
PL350902A1 (en) Pyridothiene diazepins, method of obtaining them and pharmacological compositions containing them
EP1427246A4 (en) DIAGNOSTIC SYSTEM, DIAGNOSTIC PROCEDURE, DIAGNOSTIC TERMINAL AND DIAGNOSTIC TERMINATION USING THE METHOD
PL341752A1 (en) Method of obtaining aryloamino hydroxyantraquinones
GB9922482D0 (en) Method of diagnosis
GB9924752D0 (en) Method of construction
AU5912100A (en) Method for determination of peptide-binding agent interaction
AU3385900A (en) Method of increasing bone volume using non-naturally-occurring selective fp agonist and dito ep1 agonist prostaglandin derivatives
PL339297A1 (en) Method of inctrasing bone volume
GB0024938D0 (en) Method of diagnosis
PL338405A1 (en) Method of obtaining 2-quinoxalincarboxylic acid
GB0026109D0 (en) An analysis method
NZ513827A (en) Methods of increasing bone volume using non-naturally-occurring FP selective agonists and antiresorptive compounds
GB9907366D0 (en) Method for expressing proteins
PL333334A1 (en) Method of obtaining silylethenes
GB2367185B (en) Method of analysis
PL336648A1 (en) Method of obtaining sodium percarbonate
PL335627A1 (en) Method of obtaining 8beta-hydroxyandrostendione

Legal Events

Date Code Title Description
AVOD Application void